Mesenteric Ischemia after Cardiac Surgery
The Thoracic and Cardiovascular Surgeon · 2024-10 · 72 (07) · 498-509
DOI: 10.1055/s-0044-1786183 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, online erschienen am 03.05.2024. Verfasst von Asen Petrov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, University Heart Center Dresden, Medical Faculty Carl Gustav Carus of the Technical University of Dresden, Technische …. Hauptthemen laut MEDLINE: Mesenteric Ischemia, Cardiac Surgical Procedures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Mesenteric ischemia (Me-Is) after cardiac surgery is underreported in present literature but has still earned the bad reputation of a dismal prognosis. This study adds clinical outcomes in a large patient cohort.
Methods
Between 2009 and 2019 of the 22,590 patients undergoing cardiac surgery at our facility 106 (0.47%) developed Me-Is postoperatively. Retrospective patient data was analyzed. Additionally, patients were stratified by outcome—survivors and nonsurvivors.
Results
Patients were predominantly male (n = 68, 64.2%), mean age was 71.2 ± 9.3 years. Most procedures were elective (n = 85, 80.2%) and comprised of more complex combined procedures (50.9%) and redos (17.9%). Mean EuroSCORE II averaged 10.9 ± 12.2%. Survival at 30 days was 49.1% (n = 52). Clinical baseline and procedural characteristics did not differ significantly between survivors and nonsurvivors. The median postoperative interval until symptom onset was 5 days in both groups. Survivors were more frequently diagnosed by computed tomography and nonsurvivors based on clinical symptoms. Me-Is was predominantly nonocclusive (n = 84, 79.2%). Laparotomy was the main treatment in both groups (n = 45, 78.8% vs. n = 48, 88.9%, p = 0.94). Predictors of mortality were maximum norepinephrine doses (hazard ratio [HR] 8.29, confidence interval [CI] 3.39–20.26, p < 0.0001), lactate levels (HR 1.06, CI 1.03–1.09), and usage of inotropes (HR 2.46, CI 1.41–4.30).
Conclusion
The prognosis of Me-Is following cardiac surgery is poor—independently from diagnostic or treatment patterns. There exists a significant asymptomatic time period postoperatively, in which pathophysiologic processes seem to cross the Rubicon. After clinical demarcation, the further course can almost no longer be influenced.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Cardiac Surgery, University Heart Center Dresden, Medical Faculty Carl Gustav Carus of the Technical University of Dresden, Technische Universität Dresden, Dresden, Sachsen, Germany.
- Division of Vascular and Endovascular Surgery, Department for Visceral-, Thoracic and Vascular Surgery, Medical Faculty Carl Gustav Carus and University Hospital, Technische Universität Dresden, Dresden, Sachsen, German…
ORCID-Profile: Asen Petrov
Zitieren
APA
Petrov, A., Taghizadeh-Waghefi, A., Hotz, F., Georgi, C., Matschke, K. E., Busch, A., & Wilbring, M. (2024). Mesenteric Ischemia after Cardiac Surgery. The Thoracic and Cardiovascular Surgeon, 72(07), 498-509. https://doi.org/10.1055/s-0044-1786183
Vancouver
Petrov A, Taghizadeh-Waghefi A, Hotz F, Georgi C, Matschke KE, Busch A, et al. Mesenteric Ischemia after Cardiac Surgery. The Thoracic and Cardiovascular Surgeon. 2024;72(07):498-509. doi:10.1055/s-0044-1786183
BibTeX
@article{Petrov2024,
author = {Petrov, Asen and Taghizadeh-Waghefi, Ali and Hotz, Fabio and Georgi, Christian and Matschke, Klaus Ehrhard and Busch, Albert and Wilbring, Manuel},
title = {Mesenteric Ischemia after Cardiac Surgery},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2024},
volume = {72},
number = {07},
pages = {498--509},
doi = {10.1055/s-0044-1786183}
}
EUVIMED